Font Size: a A A
Keyword [Receptor tyrosine]
Result: 181 - 200 | Page: 10 of 10
181. Study Of Isolation And Identification Of Tumorstem-like Cell From ID8 Cell Line And Its Vaccine Effects
182. Docetaxel Plus Platinum Versus Pemetrexed Plus Platinum As Subsequent Treatment Of Advanced Lung Adenocarcinoma With Acquired Resistance To EGFR-TKI,Gefitinib
183. Clinical Observation Of EGFR-TKIs Combined With WBRT Versus EGFR-TKIs Alone In The Treatment Of Patients With EGFR-sensitive Mutant Lung Adenocarcinoma With Inital Brain Metastases
184. The Analysis Of Treatment Effect By Different Strategies For Advanced Lung Adenocarcinoma Patients With EGFR Sensitive Mutation Positive
185. The Study On The Mechanism Of CXCR4 In T Cell Acute Lymphoblastic Leukemia Cell Migration
186. Clinical Study On The Influential Factors Of Aquired Resistance To EGFR-TKI And The Treatment Strategy After Drug Resistance In Non-small Cell Lung Cancer
187. Study On EGFR-TKIs Resistance And BIN1 Expression In Lung Adenocarcinoma
188. The Case Analysis Of Epidermal Growth Factor Receptor-targeted Therapies Combined With Chemoradiotherapy In Esophageal Squamous Cell Carcinoma And Literature Review
189. Clinical Outcomes Of Surgery Combined With Targeted Therapy In Non-Small Cell Lung Cancer
190. Dynamic Monitoring Of Lymphocyte Subpopulation During The EGFR-TKI Therapy For Predicting The Efficacy And Resistance Of EGFR-TKI In EGFR Mutated Lung Cancer Patients
191. The Role Of Receptor Tyrosine Kinase Axl In The Pathogenesis Of Intracranial Aneurysms
192. Model To Predict PFS Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Chinese Han Lung Adenocarcinoma Population
193. Study On The Changes Of Plasma T790M Gene Mutation After TKI Therapy In Patients With Advanced Non-small Cell Lung Cancer
194. Clinical Observation Of Xiao Zhen Tang On EGFR-TKIs Related Rash(Yin Deficiency Type) Of Lung Adenocarcinoma
195. Study On The Clinical Characteristics,Diagnosis And Treatment Of MuSK Antibody Positive Myasthenia Gravis
196. Study On The Relationship Between The Expression Level Of MiR-221 In Peripheral Blood And The Acquired Resistance Of The First Generation Of EGFR-TKIs In Lung Cancer
197. Expression Of ROR1 In Triple-negative Breast Cancer And Its Prognostic Significance
198. Functional Identification And Regulation Mechanism Of Podocyte Receptor Tyrosine Kinase(TYRO3)
199. The Effect Of Concurrent TP53 Mutations On Clinical Efficacy Of First-generation EGFR-TKIs In Patients With EGFR-mutated Advanced NSCLC
200. Influence Of TMB And TP53 Gene Mutation On The Efficacy Of Targeted Drugs In Patients With Advanced Lung Cancer Harboring EGFR-sensitive Mutations
  <<First  <Prev  Next>  Last>>  Jump to